SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-08-000835
Filing Date
2008-04-23
Accepted
2008-04-23 15:58:41
Documents
6
Period of Report
2008-06-12
Effectiveness Date
2008-04-23

Document Format Files

Seq Description Document Type Size
1 NOTICE OF PROXY STATEMENT dusapharma_nps.htm DEF 14A 533260
2 GRAPHIC gusapharma_nps1x1x1.jpg GRAPHIC 13313
3 GRAPHIC gusapharma_nps1x1x2.jpg GRAPHIC 7215
4 GRAPHIC gusapharma_nps1x1x3.jpg GRAPHIC 7030
5 GRAPHIC gusapharma_nps1x3x1.jpg GRAPHIC 6498
6 GRAPHIC gusapharma_nps1x3x2.jpg GRAPHIC 10221
  Complete submission text file 0001206774-08-000835.txt   596582
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Filer) CIK: 0000879993 (see all company filings)

IRS No.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31533 | Film No.: 08771832
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1